Skip to main content

Find Clinical Trials

Clinical trial condition

GERD

Explore clinical trials studying GERD. Study availability and eligibility vary by location and protocol.

140 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

GERD trial results

Completed

Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease

NCT01132638

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Investigational site Belo Horizonte/MG, Brazil

Investigational site Curitiba/PR, Brazil

Investigational site Goiânia/GO, Brazil

Investigational site Porto Alegre/RS, Brazil

View Trial Details

Completed

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

NCT00261339

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations: Altana Pharma/Nycomed Antrim, United Kingdom

Altana Pharma/Nycomed Ashford, United Kingdom

Altana Pharma/Nycomed Aston Clinton, Aylesbury, United Kingdom

Altana Pharma/Nycomed Atherstone, Warwick, United Kingdom

View all 45 locations

View Trial Details

Completed

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

NCT00336219

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Altana Pharma/Nycomed Bondi Junction, Australia

Altana Pharma/Nycomed Box Hill, Victoria, Australia

Altana Pharma/Nycomed New South Wales, Australia

Altana Pharma/Nycomed South Australia, Australia

View all 40 locations

View Trial Details

Completed

Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

NCT01079884

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Digestive and Liver Disease Specialists Norfolk, Virginia, United States

View Trial Details

Completed

Impact of GERD on Daily Life (NIS)

NCT00545883

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +6 more
Locations: Research Site Aarschot, Belgium

Research Site Aartselaar, Belgium

Research Site Alken, Belgium

Research Site Angleur, Belgium

View all 112 locations

View Trial Details

Completed

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

NCT01260935

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +6 more
Locations: Swedish Medical Center Cancer Institute Seattle, Washington, United States

View Trial Details

Completed

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

NCT01509261

Conditions: Deglutition Disorders, Digestive System Diseases, Erosive Esophagitis, +5 more
Locations: Local Institution Seoul, South Korea

Local Institution Seoul, South Korea

Local Institution Seoul, South Korea

Local Institution Seoul, South Korea

View all 19 locations

View Trial Details

Completed

The Utility of Nexium in Chronic Cough and Reflux Disease

NCT00287339

Conditions: Cough, Deglutition Disorders, Digestive System Diseases, +10 more
Locations: UNC Gastroenterology, UNC Pulmonology, UNC ENT Chapel Hill, North Carolina, United States

View Trial Details

Completed

An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease

NCT01134367

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Research Site Belgrade, Serbia

Research Site Leskovac, Serbia

Research Site Niš, Serbia

Research Site Novi Sad, Serbia

View Trial Details

Completed

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00703534

Conditions: Acid Reflux Disease, Deglutition Disorders, Digestive System Diseases, +10 more
Locations: Research Site Athens, Alabama, United States

Research Site Tucson, Arizona, United States

Research Site Little Rock, Arkansas, United States

Research Site Sherwood, Arkansas, United States

View all 84 locations

View Trial Details